Evidence map›Paper›PMID 40198441›Full record

ArticleMedical & biological engineering & computing2025

A machine learning approach for type 2 diabetes diagnosis and prognosis using tailored heterogeneous feature subsets.

J Ramón Navarro-Cerdán, Pedro Pons-Suñer, Laura Arnal, Joaquim Arlandis, Rafael Llobet, Juan-Carlos Perez-Cortes, Francisco Lara-Hernández, Celeste Moya-Valera, Maria Elena Quiroz-Rodriguez, Gemma Rojo-Martinez and 8 more

Abstract read
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

J Ramón Navarro-CerdánUniversitat Politècnica de València, Camí de Vera, s/n, 46022, València, Spain. jonacer@upv.es.ORCID https://orcid.org/0000-0002-6692-5941
Pedro Pons-SuñerITI, Instituto Tecnológico de Informática, Camino de Vera s/n, 46022, València, Spain.ORCID https://orcid.org/0009-0000-3476-295X
Laura ArnalITI, Instituto Tecnológico de Informática, Camino de Vera s/n, 46022, València, Spain.ORCID https://orcid.org/0000-0002-2173-8886
Joaquim ArlandisUniversitat Politècnica de València, Camí de Vera, s/n, 46022, València, Spain.ORCID https://orcid.org/0000-0003-2472-8883
Rafael LlobetUniversitat Politècnica de València, Camí de Vera, s/n, 46022, València, Spain.ORCID https://orcid.org/0000-0002-8278-9740
Juan-Carlos Perez-CortesUniversitat Politècnica de València, Camí de Vera, s/n, 46022, València, Spain.ORCID https://orcid.org/0000-0001-6506-090X
Francisco Lara-HernándezGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, València, Spain.ORCID https://orcid.org/0000-0002-5167-035X
Celeste Moya-ValeraGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, València, Spain.ORCID https://orcid.org/0000-0003-4699-6010
Maria Elena Quiroz-RodriguezGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, València, Spain.ORCID https://orcid.org/0000-0002-3295-4509
Gemma Rojo-MartinezCIBERDEM, ISCIII, Madrid, Spain.ORCID https://orcid.org/0000-0003-2179-2134
Sergio ValdésCIBERDEM, ISCIII, Madrid, Spain.ORCID https://orcid.org/0000-0001-8623-4331
Eduard MontanyaCIBERDEM, ISCIII, Madrid, Spain.ORCID https://orcid.org/0000-0003-2518-9076
Alfonso L Calle-PascualMedical School, University Complutense, Madrid, Spain.ORCID https://orcid.org/0000-0002-3628-9323
Josep Franch-NadalCIBERDEM, ISCIII, Madrid, Spain.ORCID https://orcid.org/0000-0002-5175-1555
Elias DelgadoDepartment of Endocrinology and Nutrition, Central University Hospital of Asturias, Health Research Institute of the Principality of Asturias, Oviedo, Spain.ORCID https://orcid.org/0000-0001-6114-9712
Luis CastañoCIBERDEM, ISCIII, Madrid, Spain.ORCID https://orcid.org/0000-0003-0437-9401
Ana-Bárbara García-GarcíaGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, València, Spain.ORCID https://orcid.org/0000-0002-2162-6606
Felipe Javier ChavesGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, València, Spain.ORCID https://orcid.org/0000-0001-8009-3689

Funding

Cervera Network of Excellence in Data-Based Enabling Technologies (AI4ES) CER-20211030CIBERDEM CB07/08/0018IVACE and the European Union through FEDER funds, PANAKEIA IMDEEA/2023/92, IMAMCA/2023/11Ministerio de Ciencia e Innovación and Instituto de Salud Carlos III (ISCIII) PI17/00544, PI21/00506
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is becoming one of the leading health problems in Western societies, diminishing quality of life and consuming a significant share of healthcare resources. This study presents machine learning models for T2D diagnosis and prognosis, developed using heterogeneous data from a Spanish population dataset (Di@bet.es study). The models were trained exclusively on individuals classified as controls and undiagnosed diabetics, ensuring that the results are not influenced by treatment effects or behavioral changes due to disease awareness. Two data domains are considered: environmental (patient lifestyle questionnaires and measurements) and clinical (biochemical and anthropometric measurements). The preprocessing pipeline consists of four key steps: geospatial data extraction, feature engineering, missing data imputation, and quasi-constancy filtering. Two working scenarios (Environmental and Healthcare) are defined based on the features used, and applied to two targets (diagnosis and prognosis), resulting in four distinct models. The feature subsets that best predict the target have been identified based on permutation importance and sequential backward selection, reducing the number of features and, consequently, the cost of predictions. In the Environmental scenario, models achieved an AUROC of 0.86 for diagnosis and 0.82 for prognosis. The Healthcare scenario performed better, with an AUROC of 0.96 for diagnosis and 0.88 for prognosis. A partial dependence analysis of the most relevant features is also presented. An online demo page showcasing the Environmental and Healthcare T2D prognosis models is available upon request.

Indexed as

Diabetes Mellitus, Type 2Machine LearningAgedFemaleHumansMaleMiddle AgedPrognosisSpainSurveys and QuestionnairesDiagnosis and prognosis risk estimationFeature selectionGeospatial data augmentationHeterogeneous missing data imputationQuasi-constancy heuristicType 2 diabetes mellitus

Identifiers

PMID40198441
PMCPMC12402034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.